Frontlight ResearchEarly access
Atopic dermatitis (eczema) trials in South Korea
4 of 6 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
- Where
- Cheonan
- Age
- 19 years to 70 years
- People
- 286
- Run by
- EHL Bio Co., Ltd.
See details and how to joinNCT07377838 - Phase 3Active, not recruitingA Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Where
- Ansan-si, Gwangju, Seoul
- Age
- 6 months to 11 years
- People
- 195 worldwide
- Run by
- LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00 - Phase 2Taking peoplePlatform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Where
- Ansan, Seoul
- Age
- 18 years to 100 years
- People
- 224 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00 - Phase 2Taking peopleA Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
- Where
- Ansan
- Age
- 19 years and over
- People
- 162
- Run by
- HK inno.N Corporation
See details and how to joinNCT07073677